Page last updated: 2024-08-26

yttrium radioisotopes and Lymph Node Metastasis

yttrium radioisotopes has been researched along with Lymph Node Metastasis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, G; Jia, Z; McKinney, JM; Paz-Fumagalli, R; Sella, DM; Wang, W1
Bencze, A; Igaz, P; Leiszter, K; Nagy, Z; Patócs, A; Rácz, K; Szücs, N1
Bugiantella, W; Carnelutti, A; Leo, CA; Lorenzin, D; Pravisani, R; Risaliti, A; Soardo, G; Umberto, B1
Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY1
Baete, K; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C1
Ahmadi, MA; Esmaeli, B; McLaughlin, P; Murray, JL; Naderi, A; Romaguera, J; Singh, S; White, CA1
Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY1

Trials

1 trial(s) available for yttrium radioisotopes and Lymph Node Metastasis

ArticleYear
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:6

    Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes

2002

Other Studies

6 other study(ies) available for yttrium radioisotopes and Lymph Node Metastasis

ArticleYear
Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:9

    Topics: Aged; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Yttrium Radioisotopes

2017
[Carcinoid heart disease].
    Orvosi hetilap, 2013, Apr-07, Volume: 154, Issue:14

    Topics: Carcinoid Heart Disease; Diagnosis, Differential; Echocardiography, Doppler, Color; Flushing; Humans; Ileal Neoplasms; Lymphatic Metastasis; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Tomography, X-Ray Computed; Yttrium Radioisotopes

2013
Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
    Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Sorafenib; Thrombosis; Treatment Outcome; Yttrium Radioisotopes

2016
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
    Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:2

    Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes

2010
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jul-01, Volume: 29, Issue:19

    Topics: Adult; Disease Progression; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Somatostatin; Tomography, X-Ray Computed; Yttrium Radioisotopes

2011
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:9

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Female; Humans; Immunotherapy; Lymphatic Metastasis; Lymphoma, B-Cell; Male; Orbital Neoplasms; Rituximab; Tomography, X-Ray Computed; Yttrium Radioisotopes

2002